A bipartisan group of senators introduced a bill in early August to clarify requirements, increase oversight, and reform the payment and data infrastructure of the 340B Drug Pricing Program. Read More »
CMS is moving forward with it’s plans for a mandatory nationwide rollout of the Comprehensive Joint Replacement Expanded (CJR-X), according to the 2027 Inpatient Prospective Payment System (IPPS) final rule.Read More »
CMS recently launched the Medicare GLP-1 Bridge, a short-term demonstration that provides eligible Part D beneficiaries with access to certain glucagon‐like peptide‐1 (GLP-1) drugs.Read More »
